Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug
Authors:
- Hee Sook LeeHLHee Sook Lee
- Taejeong BaeTBTaejeong Bae
- Ji-Hyun LeeJLJi-Hyun Lee
- Dae Gyu KimDKDae Gyu Kim
- Young Sun OhYOYoung Sun Oh
- Yeongjun JangYJYeongjun Jang
- Ji-Tea KimJKJi-Tea Kim
- Jong-Jun LeeJLJong-Jun Lee
- Alessio InnocentiAIAlessio Innocenti
- Claudiu T SupuranClaudiu T Supuran
- Luonan ChenLCLuonan Chen
- Kyoohyoung RhoKRKyoohyoung Rho
Open Access
- 2 July 2012
- journal article
- research article
- Published by Springer Nature in BMC Systems Biology
- Vol. 6 (1) , 1-10
Abstract
Background: The process of drug discovery and development is time-consuming and costly, and the probability of success is low. Therefore, there is rising interest in repositioning existing drugs for new medical indications. When successful, this process reduces the risk of failure and costs associated with de novo drug development. However, in many cases, new indications of existing drugs have been found serendipitously. Thus there is a clear need for establishment of rational methods for drug repositioning. Results: In this study, we have established a database we call “PharmDB” which integrates data associated with disease indications, drug development, and associated proteins, and known interactions extracted from various established databases. To explore linkages of known drugs to diseases of interest from within PharmDB, we designed the Shared Neighborhood Scoring (SNS) algorithm. And to facilitate exploration of tripartite (Drug-Protein-Disease) network, we developed a graphical data visualization software program called phExplorer, which allows us to browse PharmDB data in an interactive and dynamic manner. We validated this knowledge-based tool kit, by identifying a potential application of a hypertension drug, benzthiazide (TBZT), to induce lung cancer cell death. Conclusions: By combining PharmDB, an integrated tripartite database, with Shared Neighborhood Scoring (SNS) algorithm, we developed a knowledge platform to rationally identify new indications for known FDA approved drugs, which can be customized to specific projects using manual curation. The data in PharmDB is open access and can be easily explored with phExplorer and accessed via BioMart web service (http://www.i-pharm.org/, http://biomart.i-pharm.org/).Keywords
This publication has 33 references indexed in Scilit:
- Finding undetected protein associations in cell signaling by belief propagationProceedings of the National Academy of Sciences, 2010
- Entrez Gene: gene-centered information at NCBINucleic Acids Research, 2010
- The Comparative Toxicogenomics Database: update 2011Nucleic Acids Research, 2010
- Update of TTD: Therapeutic Target DatabaseNucleic Acids Research, 2009
- MINT, the molecular interaction database: 2009 updateNucleic Acids Research, 2009
- Predicting new molecular targets for known drugsNature, 2009
- ChemBank: a small-molecule screening and cheminformatics resource databaseNucleic Acids Research, 2007
- Systems biology in drug discoveryNature Biotechnology, 2004
- The Genetic Association DatabaseNature Genetics, 2004
- The Database of Interacting Proteins: 2004 updateNucleic Acids Research, 2004